Vaxart addresses FAQs about reverse stock split proposal
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 12 2025
0mins
Should l Buy ?
Reverse Stock Split Proposal: Vaxart is proposing a reverse stock split to comply with Nasdaq's minimum bid price requirement of $1.00, aiming to avoid delisting and maintain its listing status.
Impact on Shareholders: The reverse stock split will not change the overall value of shareholders' investments or cause dilution; instead, shareholders will own fewer shares at a higher anticipated price per share.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
